Cargando…

Clinical practice guidelines within the Southern African development community: a descriptive study of the quality of guideline development and concordance with best evidence for five priority diseases

BACKGROUND: Reducing the burden of disease relies on availability of evidence-based clinical practice guidelines (CPGs). There is limited data on availability, quality and content of guidelines within the Southern African Development Community (SADC). This evaluation aims to address this gap in know...

Descripción completa

Detalles Bibliográficos
Autores principales: Kredo, Tamara, Gerritsen, Annette, van Heerden, Johan, Conway, Shaun, Siegfried, Nandi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3286374/
https://www.ncbi.nlm.nih.gov/pubmed/22221856
http://dx.doi.org/10.1186/1478-4505-10-1
_version_ 1782224543414222848
author Kredo, Tamara
Gerritsen, Annette
van Heerden, Johan
Conway, Shaun
Siegfried, Nandi
author_facet Kredo, Tamara
Gerritsen, Annette
van Heerden, Johan
Conway, Shaun
Siegfried, Nandi
author_sort Kredo, Tamara
collection PubMed
description BACKGROUND: Reducing the burden of disease relies on availability of evidence-based clinical practice guidelines (CPGs). There is limited data on availability, quality and content of guidelines within the Southern African Development Community (SADC). This evaluation aims to address this gap in knowledge and provide recommendations for regional guideline development. METHODS: We prioritised five diseases: HIV in adults, malaria in children and adults, pre-eclampsia, diarrhoea in children and hypertension in primary care. A comprehensive electronic search to locate guidelines was conducted between June and October 2010 and augmented with email contact with SADC Ministries of Health. Independent reviewers used the AGREE II tool to score six quality domains reporting the guideline development process. Alignment of the evidence-base of the guidelines was evaluated by comparing their content with key recommendations from accepted reference guidelines, identified with a content expert, and percentage scores were calculated. FINDINGS: We identified 30 guidelines from 13 countries, publication dates ranging from 2003-2010. Overall the 'scope and purpose' and 'clarity and presentation' domains of the AGREE II instrument scored highest, median 58%(range 19-92) and 83%(range 17-100) respectively. 'Stakeholder involvement' followed with median 39%(range 6-75). 'Applicability', 'rigour of development' and 'editorial independence' scored poorly, all below 25%. Alignment with evidence was variable across member states, the lowest scores occurring in older guidelines or where the guideline being evaluated was part of broader primary healthcare CPG rather than a disease-specific guideline. CONCLUSION: This review identified quality gaps and variable alignment with best evidence in available guidelines within SADC for five priority diseases. Future guideline development processes within SADC should better adhere to global reporting norms requiring broader consultation of stakeholders and transparency of process. A regional guideline support committee could harness local capacity to support context appropriate guideline development.
format Online
Article
Text
id pubmed-3286374
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-32863742012-02-25 Clinical practice guidelines within the Southern African development community: a descriptive study of the quality of guideline development and concordance with best evidence for five priority diseases Kredo, Tamara Gerritsen, Annette van Heerden, Johan Conway, Shaun Siegfried, Nandi Health Res Policy Syst Research BACKGROUND: Reducing the burden of disease relies on availability of evidence-based clinical practice guidelines (CPGs). There is limited data on availability, quality and content of guidelines within the Southern African Development Community (SADC). This evaluation aims to address this gap in knowledge and provide recommendations for regional guideline development. METHODS: We prioritised five diseases: HIV in adults, malaria in children and adults, pre-eclampsia, diarrhoea in children and hypertension in primary care. A comprehensive electronic search to locate guidelines was conducted between June and October 2010 and augmented with email contact with SADC Ministries of Health. Independent reviewers used the AGREE II tool to score six quality domains reporting the guideline development process. Alignment of the evidence-base of the guidelines was evaluated by comparing their content with key recommendations from accepted reference guidelines, identified with a content expert, and percentage scores were calculated. FINDINGS: We identified 30 guidelines from 13 countries, publication dates ranging from 2003-2010. Overall the 'scope and purpose' and 'clarity and presentation' domains of the AGREE II instrument scored highest, median 58%(range 19-92) and 83%(range 17-100) respectively. 'Stakeholder involvement' followed with median 39%(range 6-75). 'Applicability', 'rigour of development' and 'editorial independence' scored poorly, all below 25%. Alignment with evidence was variable across member states, the lowest scores occurring in older guidelines or where the guideline being evaluated was part of broader primary healthcare CPG rather than a disease-specific guideline. CONCLUSION: This review identified quality gaps and variable alignment with best evidence in available guidelines within SADC for five priority diseases. Future guideline development processes within SADC should better adhere to global reporting norms requiring broader consultation of stakeholders and transparency of process. A regional guideline support committee could harness local capacity to support context appropriate guideline development. BioMed Central 2012-01-05 /pmc/articles/PMC3286374/ /pubmed/22221856 http://dx.doi.org/10.1186/1478-4505-10-1 Text en Copyright ©2012 Kredo et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Kredo, Tamara
Gerritsen, Annette
van Heerden, Johan
Conway, Shaun
Siegfried, Nandi
Clinical practice guidelines within the Southern African development community: a descriptive study of the quality of guideline development and concordance with best evidence for five priority diseases
title Clinical practice guidelines within the Southern African development community: a descriptive study of the quality of guideline development and concordance with best evidence for five priority diseases
title_full Clinical practice guidelines within the Southern African development community: a descriptive study of the quality of guideline development and concordance with best evidence for five priority diseases
title_fullStr Clinical practice guidelines within the Southern African development community: a descriptive study of the quality of guideline development and concordance with best evidence for five priority diseases
title_full_unstemmed Clinical practice guidelines within the Southern African development community: a descriptive study of the quality of guideline development and concordance with best evidence for five priority diseases
title_short Clinical practice guidelines within the Southern African development community: a descriptive study of the quality of guideline development and concordance with best evidence for five priority diseases
title_sort clinical practice guidelines within the southern african development community: a descriptive study of the quality of guideline development and concordance with best evidence for five priority diseases
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3286374/
https://www.ncbi.nlm.nih.gov/pubmed/22221856
http://dx.doi.org/10.1186/1478-4505-10-1
work_keys_str_mv AT kredotamara clinicalpracticeguidelineswithinthesouthernafricandevelopmentcommunityadescriptivestudyofthequalityofguidelinedevelopmentandconcordancewithbestevidenceforfiveprioritydiseases
AT gerritsenannette clinicalpracticeguidelineswithinthesouthernafricandevelopmentcommunityadescriptivestudyofthequalityofguidelinedevelopmentandconcordancewithbestevidenceforfiveprioritydiseases
AT vanheerdenjohan clinicalpracticeguidelineswithinthesouthernafricandevelopmentcommunityadescriptivestudyofthequalityofguidelinedevelopmentandconcordancewithbestevidenceforfiveprioritydiseases
AT conwayshaun clinicalpracticeguidelineswithinthesouthernafricandevelopmentcommunityadescriptivestudyofthequalityofguidelinedevelopmentandconcordancewithbestevidenceforfiveprioritydiseases
AT siegfriednandi clinicalpracticeguidelineswithinthesouthernafricandevelopmentcommunityadescriptivestudyofthequalityofguidelinedevelopmentandconcordancewithbestevidenceforfiveprioritydiseases